Found: 17
Select item for more details and to access through your institution.
Development of a drug–device combination for fluorescence-guided surgery in neuroendocrine tumors.
- Published in:
- Journal of Biomedical Optics, 2020, v. 25, n. 12, p. 126002, doi. 10.1117/1.JBO.25.12.126002
- By:
- Publication type:
- Article
Blood-based Proteomic Signatures Associated With MENI-related Duodenopancreatic Neuroendocrine Tumor Progression.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 12, p. 3260, doi. 10.1210/clinem/dgad315
- By:
- Publication type:
- Article
A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Fluorouracil, Doxorubicin with Streptozocin and Subsequent Therapies in Pancreatic Neuroendocrine Tumors.
- Published in:
- Neuroendocrinology, 2022, v. 112, n. 1, p. 34, doi. 10.1159/000514339
- By:
- Publication type:
- Article
Development of the Functional Assessment of Cancer Therapy-Carcinoid Syndrome Symptom Index.
- Published in:
- Neuroendocrinology, 2021, v. 111, n. 9, p. 850, doi. 10.1159/000511482
- By:
- Publication type:
- Article
Shifting Paradigms in the Pathophysiology and Treatment of Carcinoid Crisis.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 5, p. 3072, doi. 10.1245/s10434-022-11371-0
- By:
- Publication type:
- Article
Comparison of Design, Eligibility, and Outcomes of Neuroendocrine Neoplasm Trials Initiated From 2000 to 2009 vs 2010 to 2020.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 10, p. e2131744, doi. 10.1001/jamanetworkopen.2021.31744
- By:
- Publication type:
- Article
Discrepancies in endpoints between clinical trial protocols and clinical trial registration in randomized trials in oncology.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Assessment of change in quality of life, carcinoid syndrome symptoms and healthcare resource utilization in patients with carcinoid syndrome.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pancreatic neuroendocrine neoplasms: a 2022 update for radiologists.
- Published in:
- Abdominal Radiology, 2022, v. 47, n. 12, p. 3962, doi. 10.1007/s00261-022-03466-9
- By:
- Publication type:
- Article
A Systematic Review of Economic and Quality-of-Life Research in Carcinoid Syndrome.
- Published in:
- PharmacoEconomics, 2021, v. 39, n. 11, p. 1271, doi. 10.1007/s40273-021-01071-0
- By:
- Publication type:
- Article
Carcinoid Syndrome and Costs of Care During the First Year After Diagnosis of Neuroendocrine Tumors Among Elderly Patients.
- Published in:
- Oncologist, 2017, v. 22, n. 12, p. 1451, doi. 10.1634/theoncologist.2017-0149
- By:
- Publication type:
- Article
A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-561
- By:
- Publication type:
- Article
Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 9, p. 1001, doi. 10.1093/jnci/djad096
- By:
- Publication type:
- Article
Is estrogen exposure a protective factor for pancreatic neuroendocrine tumours in female patients with multiple endocrine neoplasia syndrome type 1?
- Published in:
- Clinical Endocrinology, 2017, v. 86, n. 6, p. 791, doi. 10.1111/cen.13324
- By:
- Publication type:
- Article
A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers.
- Published in:
- 2014
- By:
- Publication type:
- journal article